ISOLATED TIE-LIGAND-4 AND ITS ISOLATED FIBRINOGEN-LIKE DOMAIN; ISOLATED NUCLEIC ACID MOLECULE ENCODING INDICATED LIGAND; VECTOR COMPRISING INDICATED NUCLEIC ACID; METHOD FOR PREPARING HOST-CELL TRANSFORMED WITH INDICATED VECTOR; METHOD FOR PREPARING TIE-LIGAND-4; CONJUGATE COMPRISING INDICATED LIGAND; LIGAND-BODY COMPRISING INDICATED FIBRINOGEN-LIKE DOMAIN Russian patent published in 2004 - IPC

Abstract RU 2242514 C2

FIELD: biotechnology, molecular biology, medicine, proteins.

SUBSTANCE: invention describes nucleotide sequence encoding new polypeptide (TIE-ligand-4) that relates to the family of TIE-ligands. Fragment of this nucleotide sequence relating to fibrinogen-like domain of new polypeptide is determined. Vectors comprising nucleic acid fragment with sequence encoding TIE-ligand-4 or its fibrinogen-like domain are constructed and used for transformation of host-cells and preparing corresponding recombinant polypeptides. Application of TIE-ligand-4 as component of conjugate with cytotoxic agent and its fibrinogen-like domain for formation of "ligand-body" is proposed.

EFFECT: improved preparing method, valuable biological and medicinal properties of ligand.

14 cl, 10 dwg, 14 ex

Similar patents RU2242514C2

Title Year Author Number
ISOLATED NUCLEIC ACID MOLECULE ENCODING CHIMERIC TIE-2-LIGAND (VARIANTS), CHIMERIC OR MODIFIED TIE-2-LIGAND AND METHOD FOR ITS PREPARING, VECTOR, METHOD FOR PREPARING SYSTEM VECTOR-HOST, CONJUGATE, PHARMACEUTICAL COMPOSITION 1997
  • Dehvis Sehmjuel'
  • Jankopoulos Dzhordzh D.
RU2233880C2
NUCLEIC ACID MOLECULE ENCODING LIGAND TIE-2, LIGAND TIE-2 AND METHOD FOR ITS PREPARING, VECTOR, STRAIN OF CELLS COS, ANTIBODY, CONJUGATE OF LIGAND TIE-2, LIGAND BODY, PHARMACEUTICAL COMPOSITION, METHOD FOR PROPHYLAXIS OR ATTENUATION OF NEOVASCULARIZATION AND METHOD FOR IDENTIFICATION OF TIE-2 RECEPTOR ANTAGONIST 1995
  • Dehvis Sehmjuehl'
  • Bruno Dzhoan
  • Goldfarb Mitchell
  • Oldrich Tomas Kh.
  • Mehjsonp'Er Piter S.
  • Radzievski Cheslav
  • Dzhons Pamela F.
  • Jankopulos Dzhordzh D.
RU2233330C2
ISOLATED NUCLEIC ACID MOLECULE ENCODING LIGAND TIE-2, LIGAND TIE-2 AND METHOD FOR PREPARING, PLASMID (VARIANTS), ANTIBODY, CONJUGATE, LIGAND BODY, PHARMACEUTICAL COMPOSITION, METHOD FOR STIMULATING NEO-VASCULARIZATION, METHOD FOR CELL MAINTENANCE, METHOD FOR IDENTIFYING TIE-2 RECEPTOR ANTAGONIST 1995
  • Dehvis Sehmjuehl'
  • Bruno Dzhoan
  • Goldfarb Mitchell
  • Oldrich Tomas Kh.
  • Mehjsonp'Er Piter S.
  • Radzievski Cheslav
  • Dzhons Pamela F.
  • Jankopulos Dzhordzh D.
RU2232812C2
RECEPTOR BODY SPECIFICALLY BINDING LIGAND TIE-2, ISOLATED NUCLEIC ACID MOLECULE, PLASMID, PHARMACEUTICAL COMPOSITION AND METHOD FOR PREVENTION OR ATTENUATION OF NEOVASCULARIZATION IN MAMMALS 1995
  • Dehvis Sehmjuehl'
  • Bruno Dzhoan
  • Goldfarb Mitchell
  • Oldrich Tomas Kh.
  • Mehjsonp'Er Piter S.
  • Radzievski Cheslav
  • Dzhons Pamela F.
  • Jankopulos Dzhordzh D.
RU2216593C2
ISOLATED NUCLEIC ACID ENCODING FELINE LIGAND CD86, DIAGNOSTIC OLIGONUCLEOTIDE, CLONING VECTOR, VACCINE, METHODS FOR INDUCTION OR SUPPRESSION OF IMMUNITY IN CAT 1999
  • Kollison Ehllen V.
  • Choj In-Soo
  • Uinslou Barbara Dzh.
  • Kochran Mark D.
RU2263145C2
VECTORS CONDITIONALLY EXPRESSING THERAPEUTIC PROTEINS, HOST CELLS COMPRISING THE VECTORS, AND USES THEREOF 2011
RU2612788C2
DNA MOLECULE ENCODING POLYPEPTIDE ABLE TO BIND WITH INTRACELLULAR DOMAIN OF FAS (FAS-IC) LIGAND RECEPTOR, POLYPEPTIDE, METHOD FOR ITS PREPARING, VECTOR, METHOD FOR MODULATION OF EFFECT OF FAS-R LIGAND ON CELLS (VARIANTS), PHARMACEUTICAL COMPOSITION (VARIANTS), METHOD FOR ISOLATION AND IDENTIFICATION OF PROTEIN 1995
  • Uollakh Dehvid
  • Boldin Mark
  • Varfolomeev Evgenij
  • Mett Igor'
RU2241747C2
POLYPEPTIDE-LIGAND FLT3 (VARIANTS), POLYNUCLEOTIDE (VARIANTS), EXPRESSING VECTOR (VARIANTS), STRAIN OF CELL CHO (VARIANTS), METHOD FOR PRODUCING POLYPEPTIDE-LIGAND FLT3 (VARIANTS), PHARMACEUTICAL COMPOSITION (VARIANTS) 1994
  • Lajmehn Stjuart D.
  • Bekmann M. Patritsija
RU2220979C2
NUCLEIC ACIDS, CODING RECEPTOR CTLA-4 OF CAT, VECTORS, HOST CELLS, VACCINES, OLIGONUCLEOTIDES, POLYPEPTIDES CTLA-4 OF CAT AND METHODS FOR INDUCTION AND SUPPRESSION OF IMMUNE RESPONSE IN CAT 1999
  • Kollison Ehllen V.
  • Choj In-Soo
  • Uinslou Barbara Dzh.
  • Kochran Mark D.
RU2377302C2
ANTIBODIES AGAINST ANGIOPOIETIN-2 AND USE THEREOF 2005
  • Grin Larri L.
  • Chzhou Tsin
  • Kejt Brjus A.
  • Jan Sjao-Dun
  • Emeri Stefen Charl'Z
  • Blejki Dehvid S.
RU2394839C2

RU 2 242 514 C2

Authors

Valenzuela Dehvid M.

Dzhounz Pamela F.

Jankopoulos Dzhordzh D.

Dates

2004-12-20Published

1997-06-19Filed